See more : Sonam Clock Limited (SONAMCLOCK.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Zecotek Photonics Inc. (ZMSPF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zecotek Photonics Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Great Wall Terroir Holdings Limited (0524.HK) Income Statement Analysis – Financial Results
- Tesserent Limited (TNT.AX) Income Statement Analysis – Financial Results
- Bound and Beyond Public Company Limited (BEYOND.BK) Income Statement Analysis – Financial Results
- Genesys International Corporation Limited (GENESYS.BO) Income Statement Analysis – Financial Results
- Adcock Ingram Holdings Limited (AIP.JO) Income Statement Analysis – Financial Results
Zecotek Photonics Inc. (ZMSPF)
About Zecotek Photonics Inc.
Zecotek Photonics Inc., a photonics technology company, develops various photonics technologies and products for commercial and research applications in medical, bio-science, high-energy physics, pharmaceutical research, material processing, engineering and industrial design, and multi-media markets in Canada. The company operates through three divisions: Zecotek Imaging China, Zecotek Optronics Systems, and Zecotek Autotronics. Its imaging systems include lutetium fine silicate scintillation crystals; solid-state micro-pixel avalanche photo diode photo detectors and transistors; and integrated detector modules. The company also develops glasses-free 3D displays; and 3D auto-stereoscopic displays, and 3D printers and related technologies. The company was formerly known as Zecotek Medical Systems Inc. and changed its name to Zecotek Photonics Inc. in November 2007. Zecotek Photonics Inc. was incorporated in 1983 and is headquartered in Richmond, Canada.
| Metric | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|
| Revenue | 86.61K | 155.40K | 373.33K | 1.14M | 347.12K | 79.54K | 38.47K |
| Cost of Revenue | 281.93K | 207.02K | 362.37K | 983.97K | 248.11K | 56.84K | 0.00 |
| Gross Profit | -195.32K | -51.62K | 10.97K | 156.72K | 99.02K | 22.70K | 38.47K |
| Gross Profit Ratio | -225.52% | -33.22% | 2.94% | 13.74% | 28.53% | 28.53% | 100.00% |
| Research & Development | 821.16K | 427.90K | 997.63K | 1.11M | 1.13M | 1.49M | 902.69K |
| General & Administrative | 3.29M | 4.60M | 2.73M | 3.03M | 4.43M | 6.15M | 3.05M |
| Selling & Marketing | 177.31K | 36.32K | 32.01K | 63.72K | 44.41K | 153.99K | 64.39K |
| SG&A | 2.64M | 4.63M | 2.76M | 3.10M | 4.48M | 6.30M | 3.12M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 3.46M | 5.06M | 3.76M | 4.21M | 5.60M | 7.79M | 6.90M |
| Cost & Expenses | 3.74M | 5.27M | 4.12M | 5.19M | 5.85M | 7.85M | 6.90M |
| Interest Income | 2.79K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 214.55K | 19.39K | 37.41K | 41.38K | 49.41K | 67.34K | 74.34K |
| EBITDA | -3.44M | -6.64M | -3.71M | -4.01M | -5.46M | -8.45M | -6.80M |
| EBITDA Ratio | -3,974.39% | -3,276.40% | -993.24% | -351.77% | -1,571.84% | -9,683.83% | -10,152.86% |
| Operating Income | -3.66M | -5.11M | -3.75M | -4.05M | -5.51M | -7.77M | -3.98M |
| Operating Income Ratio | -4,222.11% | -3,288.88% | -1,003.26% | -355.39% | -1,586.07% | -9,768.49% | -10,346.08% |
| Total Other Income/Expenses | -51.77K | 1.29M | 1.01M | 34.00K | 0.00 | 688.35K | 0.00 |
| Income Before Tax | -3.71M | -3.82M | -2.74M | -4.02M | -5.51M | -7.77M | -6.86M |
| Income Before Tax Ratio | -4,281.89% | -2,457.71% | -732.73% | -352.41% | -1,586.07% | -9,768.49% | -17,834.70% |
| Income Tax Expense | -191.69K | -20.11K | -2.00 | -3.00 | 0.48 | 0.25 | 0.99 |
| Net Income | -3.52M | -3.80M | -2.74M | -4.02M | -5.51M | -7.77M | -6.86M |
| Net Income Ratio | -4,063.02% | -2,444.77% | -732.73% | -352.41% | -1,586.07% | -9,768.49% | -17,834.70% |
| EPS | -0.02 | -0.02 | -0.02 | -0.03 | -0.05 | -0.08 | -0.09 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.03 | -0.05 | -0.08 | -0.09 |
| Weighted Avg Shares Out | 164.93M | 152.76M | 131.09M | 117.42M | 108.34M | 94.24M | 74.46M |
| Weighted Avg Shares Out (Dil) | 164.93M | 152.76M | 131.09M | 117.42M | 108.34M | 94.24M | 74.46M |
Source: https://incomestatements.info
Category: Stock Reports